Next, the role of CD8+ T cells were examined, and we found that HER2-DC1 i.t. in combination with anti-HER2 antibodies treatment failed to control TUBO tumor growth in the absence of CD8+ T cells (figure 3J). This evidence concerns the gene ERBB2 and neoplasm.